Literature DB >> 16868319

Effects of rearfoot-controlling orthotic treatment on dorsiflexion of the hallux in feet with abnormal subtalar pronation: a preliminary report.

Pedro V Munuera1, Gabriel Domínguez, Inmaculada C Palomo, Guillermo Lafuente.   

Abstract

The aim of this study was to determine whether the treatment of abnormal subtalar pronation restores functional (as opposed to structural) limited dorsiflexion of the first metatarsophalangeal joint (functional hallux limitus). We studied 16 feet of eight individuals with abnormal subtalar pronation. Orthoses were made for all of the feet, and hallux dorsiflexion was measured during weightbearing. Each patient was unshod without the orthosis, unshod with the orthosis fitted on the same day, and unshod with the orthosis fitted approximately 5 months later. The results suggest that in functional hallux limitus caused by abnormal subtalar pronation, hallux dorsiflexion will gradually be restored by the use of foot orthoses to control the abnormal subtalar pronation.

Entities:  

Mesh:

Year:  2006        PMID: 16868319     DOI: 10.7547/0960283

Source DB:  PubMed          Journal:  J Am Podiatr Med Assoc        ISSN: 1930-8264


  3 in total

1.  A case-series study to explore the efficacy of foot orthoses in treating first metatarsophalangeal joint pain.

Authors:  Brian J Welsh; Anthony C Redmond; Nachiappan Chockalingam; Anne-Maree Keenan
Journal:  J Foot Ankle Res       Date:  2010-08-27       Impact factor: 2.303

2.  Influence of slope on subtalar pronation in submaximal running performance.

Authors:  Vinicius Machado de Oliveira; Guilherme Cesca Detoni; Cristhian Ferreira; Bruno Sergio Portela; Marcos Roberto Queiroga; Marcus Peikriszwili Tartaruga
Journal:  Acta Ortop Bras       Date:  2013-05       Impact factor: 0.513

3.  Rocker-sole footwear versus prefabricated foot orthoses for the treatment of pain associated with first metatarsophalangeal joint osteoarthritis: study protocol for a randomised trial.

Authors:  Hylton B Menz; Pazit Levinger; Jade M Tan; Maria Auhl; Edward Roddy; Shannon E Munteanu
Journal:  BMC Musculoskelet Disord       Date:  2014-03-15       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.